Folger Nolan Fleming Douglas Capital Management Inc. Reduces Stock Position in Procter & Gamble Company (The) $PG

Key Points

• Folger Nolan Fleming Douglas Capital Management Inc. has reduced its stake in Procter & Gamble by 1.9%, now holding 116,719 shares valued at approximately $18.6 million, which makes it their 11th largest position.
• Other institutions have increased their holdings, with Benjamin Edwards Inc. boosting its stake by over 120% to 364,378 shares, valued at $62.1 million.
• Recent analyst reports have led to decreased price targets for Procter & Gamble, with Wells Fargo lowering its target from $173 to $170, while the consensus price target is now $172.21.

Folger Nolan Fleming Douglas Capital Management Inc. reduced its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 116,719 shares of the company's stock after selling 2,225 shares during the quarter. Procter & Gamble comprises 2.1% of Folger Nolan Fleming Douglas Capital Management Inc.'s investment portfolio, making the stock its 11th biggest position. Folger Nolan Fleming Douglas Capital Management Inc.'s holdings in Procter & Gamble were worth $18,596,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Benjamin Edwards Inc. lifted its stake in shares of Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock valued at $62,098,000 after buying an additional 199,258 shares in the last quarter. Capital Investment Advisory Services LLC lifted its stake in shares of Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock valued at $6,426,000 after buying an additional 4,562 shares in the last quarter. World Investment Advisors lifted its stake in shares of Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company's stock valued at $8,677,000 after buying an additional 2,886 shares in the last quarter. Concurrent Investment Advisors LLC increased its holdings in Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock worth $20,451,000 after acquiring an additional 25,059 shares during the period. Finally, Diversify Wealth Management LLC increased its holdings in Procter & Gamble by 10.3% during the 1st quarter. Diversify Wealth Management LLC now owns 23,719 shares of the company's stock worth $3,849,000 after acquiring an additional 2,210 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider Balaji Purushothaman sold 490 shares of the company's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the sale, the insider owned 12,616 shares of the company's stock, valued at approximately $1,920,533.68. This represents a 3.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Andre Schulten sold 4,252 shares of the company's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer directly owned 53,992 shares of the company's stock, valued at $8,219,202.16. This trade represents a 7.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 in the last ninety days. 0.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts recently weighed in on PG shares. Wells Fargo & Company decreased their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday, September 25th. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. JPMorgan Chase & Co. decreased their target price on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a report on Friday. Barclays decreased their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Finally, BNP Paribas Exane decreased their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $172.21.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $149.69 on Friday. The company's fifty day moving average price is $155.24 and its 200-day moving average price is $159.48. The firm has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a one year low of $149.45 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the firm earned $1.40 EPS. The business's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.